Hermetica Superfood Encyclopedia
The Short Answer
Aforo-oyinbo contains limonoid compounds — principally azadirachtin, nimbolide, nimbin, and gedunin — that suppress proinflammatory cytokine cascades, inhibit bacterial glucosyltransferase gene expression, and scavenge reactive oxygen species through polyphenols including quercetin and luteolin. In vitro studies demonstrate that ethanolic leaf extracts inhibit SARS-CoV-2 replication in Vero E6 cells at an IC50 of 8.541 µg/mL (selectivity index >50) and reduce Streptococcus mutans gtfB gene expression at 6.25 mg/mL, providing quantified mechanistic evidence for its antimicrobial and antiviral applications.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordaforo-oyinbo neem benefits
Neem — botanical close-up
Health Benefits
**Fever Reduction and Anti-inflammatory Action**
Limonoids nimbolide and gedunin inhibit proinflammatory cytokine production and modulate immune cell populations (CD4+ and CD8+ T-cells), providing a molecular basis for the traditional use of neem leaf preparations to reduce febrile states and systemic inflammation.
**Antimicrobial Activity Against Oral and Systemic Pathogens**: Ethanolic leaf extracts inhibit Streptococcus mutans at a minimum bactericidal concentration of 6.25 mg/mL by downregulating gtfB gene expression and disrupting biofilm formation (MBIC 100 µg/mL; MBEC 300 µg/mL), supporting use in oral hygiene and infection management.
**Antioxidant and Free Radical Scavenging**
Phenolic constituents including catechin (315.404 µg/g), vanillic acid (151.947 µg/g), quercetin, and luteolin achieve 50% DPPH radical inhibition at 28.72 µg/mL and nitric oxide scavenging at 18.89 µg/mL, reducing oxidative stress implicated in digestive and systemic pathologies.
**Digestive Enzyme Inhibition**
Neem leaf extracts inhibit sucrase activity, slowing carbohydrate hydrolysis in the gastrointestinal tract and potentially attenuating postprandial glucose spikes, which may support management of digestive discomfort and metabolic conditions.
**Antiviral Potential**
In vitro testing of neem leaf extract against SARS-CoV-2 in Vero E6 cells yielded an IC50 of 8.541 µg/mL and a cytotoxic concentration (CC50) of 446.2 µg/mL, indicating a selectivity index greater than 50 and a favorable therapeutic window, though human clinical validation is absent.
**Anticancer and Apoptotic Effects (Preclinical)**
Azadirachtin and nimbolide have demonstrated cytotoxic and pro-apoptotic properties in cancer cell line studies, with antioxidant polyphenols quercetin and luteolin modulating NF-κB inflammatory pathways linked to tumor promotion, though evidence remains exclusively preclinical.
**Cardiovascular Support via Beta-Sitosterol**
The phytosterol beta-sitosterol present in neem leaf extracts competes with dietary cholesterol for intestinal absorption and modulates lipid metabolism, contributing to the plant's reputed cardiovascular protective effects observed in animal models.
Origin & History
Natural habitat
Azadirachta indica is native to the Indian subcontinent and Myanmar, thriving in tropical and subtropical semi-arid climates with well-drained soils and tolerance to drought and poor soils. The tree was introduced to West Africa, including Nigeria, where it naturalized extensively and became integrated into local ethnomedicine under Yoruba names such as Aforo-oyinbo. It is cultivated across sub-Saharan Africa, South and Southeast Asia, and parts of the Caribbean, growing best at altitudes below 700 meters in regions with annual rainfall of 400–1200 mm.
“Azadirachta indica has been employed in Ayurvedic medicine for over 4,000 years under the Sanskrit name 'Nimba,' with the Charaka Samhita and Sushruta Samhita documenting its use for skin diseases, fever, helminthiasis, and as a general antiseptic. In Yoruba ethnomedicine in southwestern Nigeria, the tree is called Aforo-oyinbo (literally translating roughly to 'the foreigner's bitter herb'), reflecting its introduced yet fully integrated status in West African healing traditions, where leaf decoctions are used for malaria-associated fevers, gastrointestinal infections, and wound cleansing. The United Nations Food and Agriculture Organization has recognized neem as a 'tree of the 21st century' given its versatility across medicine, agriculture (as a biopesticide), and environmental management. Every structural part of the tree — leaves, bark, seeds, roots, and oil — has documented traditional application across South Asian, African, and Caribbean medicinal systems, making it one of the most comprehensively utilized medicinal trees globally.”Traditional Medicine
Scientific Research
The current body of evidence for Azadirachta indica is predominantly preclinical, consisting of in vitro cell culture assays and animal model studies with no published randomized controlled human clinical trials identified in the available literature that report sample sizes, p-values, or effect sizes specific to fever or digestive indications. Antiviral activity against SARS-CoV-2 has been quantified in Vero E6 cell assays (IC50 8.541 µg/mL; CC50 446.2 µg/mL; selectivity index >50), and antibacterial potency against S. mutans has been characterized at MBC 6.25 mg/mL with biofilm inhibition at 100–300 µg/mL, providing reproducible in vitro benchmarks. Phytochemical characterization studies using HPLC, GC-MS, TLC, and NMR have robustly confirmed the presence and approximate concentrations of key bioactives such as catechin (315.404 µg/g) and vanillic acid (151.947 µg/g) in leaf fractions. The totality of evidence supports biological plausibility for its traditional uses but cannot establish clinical efficacy, safety thresholds, or optimal dosing in humans without prospective controlled trials.
Preparation & Dosage
Traditional preparation
**Aqueous Leaf Infusion (Traditional Tea)**
5–10 g) steeped in 200–250 mL boiling water for 10–15 minutes; consumed once or twice daily in West African ethnomedicine for fever and digestive complaints; no standardized clinical dose established
Dried neem leaves (.
**Ethanolic or Hydroalcoholic Leaf Extract (Research-Grade)**
72 mg/mL or µg/mL used in in vitro antimicrobial and antioxidant assays; equivalent human therapeutic doses have not been determined through pharmacokinetic bridging studies
Concentrations of 6.25–28..
**Topical Ointment or Cream**
Standardized at 0.5–2% w/w neem leaf extract in a suitable base; applied to skin lesions or inflamed areas; storage-stable formulations show no significant change in activity over 18 months.
**Neem Oil (Seed-Derived)**
Cold-pressed oil from seeds used topically for antimicrobial and anti-inflammatory purposes; not standardized for internal use; concentrations of active limonoids vary by extraction method.
**Encapsulated Leaf Powder**
250–500 mg capsules, though standardization to specific limonoid or phenolic content is inconsistent across products; no validated human dose-response data available
Commercially available in .
**Timing Note**
Traditional use favors morning administration of leaf infusions before meals for digestive applications; no pharmacokinetic data confirm optimal timing for absorption of active limonoids in humans.
Nutritional Profile
Neem leaves provide modest macronutrient content per 100 g dry weight including approximately 17–20 g protein, 4–6 g crude fat, and 20–25 g carbohydrates, alongside dietary fiber (~30 g), though nutritional consumption is limited by intensely bitter taste. Micronutrient content includes calcium (~510 mg/100 g dry leaf), phosphorus (~80 mg), and iron (~14 mg), along with ascorbic acid and carotenoids contributing to antioxidant capacity. The principal pharmacologically active phytochemicals are limonoids: azadirachtin, nimbolide, nimbin, gedunin, and salannin — quantified via GC-MS and HPLC in ethanolic extracts — alongside phenolics catechin (315.404 µg/g), vanillic acid (151.947 µg/g), quercetin, luteolin, chlorogenic acid, hydroxy-tyrosol, tyrosol, caffeic acid, ferulic acid, and ellagic acid. Bioavailability of limonoids is influenced by extraction solvent polarity (ethanolic extracts yield higher concentrations than aqueous), food matrix interactions, and first-pass hepatic metabolism; no human oral bioavailability studies have been published.
How It Works
Mechanism of Action
The limonoid class of triterpenoids — particularly nimbolide, azadirachtin, gedunin, and salannin — constitutes the primary pharmacological drivers in Azadirachta indica, acting through inhibition of proinflammatory transcription factor pathways such as NF-κB, suppression of prostaglandin synthesis, and modulation of T-lymphocyte subpopulations (CD4+ and CD8+) that regulate adaptive immune responses to fever-inducing pathogens. At the microbial level, ethanolic leaf extracts suppress gtfB gene expression in Streptococcus mutans at 6.25 mg/mL, impairing glucosyltransferase-mediated bacterial attachment to surfaces, while simultaneously disrupting mature biofilm architecture at MBIC 100 µg/mL. Antioxidant polyphenols including quercetin, luteolin, catechin, caffeic acid, and ferulic acid neutralize DPPH radicals, superoxide anions, and nitric oxide through direct hydrogen atom transfer and single-electron transfer mechanisms, reducing oxidative burden in inflamed tissues. Beta-sitosterol competes with cholesterol at intestinal brush border receptors, and sucrase enzyme inhibition by leaf extract fractions slows luminal carbohydrate digestion, providing mechanistic support for the plant's ethnomedicinal application in digestive regulation.
Clinical Evidence
No human clinical trials with defined enrollment, randomization, control arms, or reported effect sizes have been identified for Aforo-oyinbo (Azadirachta indica) in the management of fever or digestive disorders. Available quantitative data derive from in vitro models: SARS-CoV-2 inhibition in Vero E6 cells (IC50 8.541 µg/mL), S. mutans gtfB gene downregulation at 6.25 mg/mL, and DPPH radical inhibition at IC50 28.72 µg/mL. Toxicological data from cell culture indicate moderate safety margins (CC50 446.2 µg/mL for leaf extracts), but these values cannot be directly extrapolated to human pharmacokinetics or therapeutic dosing. Confidence in clinical outcomes therefore remains low, and the plant's use for fever and digestive management is currently supported only by traditional practice and mechanistically suggestive preclinical data.
Safety & Interactions
In vitro cytotoxicity data indicate a CC50 of 446.2 µg/mL for ethanolic leaf extracts in Vero E6 cells (selectivity index >50 for antiviral applications), suggesting a reasonable safety margin at antimicrobially active concentrations, but these values are not directly translatable to human systemic exposure. Neem oil taken orally has been associated with serious adverse events in children, including toxic encephalopathy, metabolic acidosis, and hepatotoxicity in case reports, and internal use of neem oil is contraindicated in pediatric populations and pregnancy due to reported abortifacient properties in animal models. Drug interaction data in humans are absent from peer-reviewed literature; however, theoretical interactions exist with immunosuppressants (given documented T-cell modulation), antidiabetic agents (via sucrase and potential insulin-sensitizing effects), and hepatically metabolized drugs given potential cytochrome P450 modulation observed in animal studies. Pregnant and lactating women should avoid oral neem preparations due to insufficient safety data and animal evidence of reproductive toxicity; maximum safe human doses have not been formally established through clinical dose-escalation studies.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Mkilifi (Azadirachta indica)Aforo-oyinboDogonyaroNeemDua gyare (Azadirachta indica)Aku Shorop (Azadirachta indica)NimbaIndian LilacMwarubaini (Azadirachta indica)Neem (Azadirachta indica A.Juss.)NimtreeAzadirachta indica
Frequently Asked Questions
What is Aforo-oyinbo used for in traditional Nigerian medicine?
In Yoruba traditional medicine in Nigeria, Aforo-oyinbo (Azadirachta indica) is primarily used as a decoction of fresh or dried leaves to manage febrile illnesses, including malaria-associated fever, gastrointestinal infections, and skin conditions. The leaves are boiled in water and consumed as a bitter tea, with the antimicrobial and anti-inflammatory properties attributed to limonoid compounds such as nimbolide and gedunin, which suppress proinflammatory cytokines and inhibit microbial growth.
What are the active compounds in neem leaves responsible for its medicinal effects?
The principal bioactive compounds in neem leaves are limonoid triterpenoids — azadirachtin, nimbolide, nimbin, gedunin, and salannin — which drive antimicrobial, anti-inflammatory, antiviral, and anticancer activities. These are complemented by phenolic antioxidants including catechin (315.404 µg/g), vanillic acid (151.947 µg/g), quercetin, luteolin, caffeic acid, and ferulic acid, with ethanolic extraction yielding the highest concentrations of all these compounds compared to aqueous methods.
Is neem (Aforo-oyinbo) safe to consume internally?
Neem leaf infusions have a long history of traditional oral use and in vitro data show a favorable cytotoxic selectivity index (>50) for leaf extracts; however, neem oil should never be taken orally, particularly by children, as case reports document toxic encephalopathy, hepatotoxicity, and metabolic acidosis following ingestion. Pregnant women should avoid all oral neem preparations due to documented abortifacient effects in animal studies, and no maximum safe human dose has been established through formal clinical trials.
Does neem have scientifically proven antiviral activity?
Neem leaf ethanolic extract has demonstrated antiviral activity against SARS-CoV-2 in Vero E6 cell assays, achieving an IC50 of 8.541 µg/mL and a cytotoxic concentration (CC50) of 446.2 µg/mL, yielding a selectivity index greater than 50, which indicates targeted antiviral action at concentrations well below cellular toxicity thresholds. However, this evidence is entirely in vitro, and no human clinical trials have validated antiviral efficacy or established safe antiviral dosing regimens for neem in infected patients.
How is neem leaf prepared for medicinal use and what dose is recommended?
The most common traditional preparation involves steeping 5–10 g of dried neem leaves in 200–250 mL of boiling water for 10–15 minutes to produce a bitter infusion consumed once or twice daily for fever or digestive complaints. Topical formulations are standardized at 0.5–2% w/w neem extract for skin applications; however, no evidence-based human oral dosage has been formally established through pharmacokinetic or clinical trial research, meaning all current dosing guidance is extrapolated from traditional practice and in vitro active concentration data.
Does neem (Aforo-oyinbo) interact with immunosuppressant medications or vaccines?
Neem leaf preparations contain compounds that modulate CD4+ and CD8+ T-cell populations, which may theoretically enhance immune responses and potentially reduce the efficacy of immunosuppressant drugs used after organ transplantation. If you are taking immunosuppressive medications or have recently received live vaccines, consult your healthcare provider before using neem supplements, as the herb's immune-stimulating properties could interfere with treatment goals.
What is the difference between neem leaf extract, neem oil, and neem powder supplements?
Neem leaf extract (ethanolic or aqueous) concentrates the active limonoids and antimicrobial compounds, offering higher potency per dose; neem oil is pressed from seeds and is used primarily for topical and agricultural applications rather than internal consumption; neem leaf powder is the dried, ground whole leaf with lower concentration but broader phytochemical profiles. For systemic anti-inflammatory and fever-reducing effects, standardized leaf extracts typically deliver more reliable bioavailability of nimbolide and gedunin than raw powder.
Which populations benefit most from neem supplementation for fever and inflammation management?
Individuals with recurrent low-grade fevers, chronic systemic inflammation, or oral pathogens (such as those with gingivitis or periodontal disease) may benefit most from neem's limonoid-mediated cytokine modulation and antimicrobial properties. However, those with autoimmune conditions requiring immune suppression, pregnant or nursing women, and children under age 12 should avoid neem without medical supervision due to its potent immune-stimulating and reproductive effects.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w aforo-oyinbo-azadirachta-indica curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
